Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
Titel:
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
Auteur:
West, Howard McCleod, Michael Hussein, Maen Morabito, Alessandro Rittmeyer, Achim Conter, Henry J Kopp, Hans-Georg Daniel, Davey McCune, Steven Mekhail, Tarek Zer, Alona Reinmuth, Niels Sadiq, Ahad Sandler, Alan Lin, Wei Ochi Lohmann, Tania Archer, Venice Wang, Lijia Kowanetz, Marcin Cappuzzo, Federico